These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15950373)

  • 1. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
    Chun TY; Gorski J
    Toxicol Appl Pharmacol; 2000 Feb; 162(3):161-5. PubMed ID: 10652244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.
    Kansra S; Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N
    PLoS One; 2010 Apr; 5(4):e10060. PubMed ID: 20419096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
    Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
    Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line.
    Bulayeva NN; Wozniak AL; Lash LL; Watson CS
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E388-97. PubMed ID: 15494610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
    Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
    J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an estrogen receptor antagonist on proliferation, prolactin secretion and growth factor expression in the MMQ pituitary prolactinoma cell line.
    Leng L; Zhang Y
    J Clin Neurosci; 2011 Dec; 18(12):1694-8. PubMed ID: 22015101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation and action of estrogen receptors alpha and beta in GH3 cells.
    Mitchner NA; Garlick C; Steinmetz RW; Ben-Jonathan N
    Endocrinology; 1999 Jun; 140(6):2651-8. PubMed ID: 10342855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
    King ML; Adler SR; Murphy LL
    Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotrope oestrogen receptor-alpha and -beta and progesterone receptor immunoreactivity after ovariectomy and exposure to oestradiol benzoate, tamoxifen or raloxifene in the rat: correlation with LH secretion.
    Sánchez-Criado JE; de Las Mulas JM; Bellido C; Aguilar R; Garrido-Gracia JC
    J Endocrinol; 2005 Jan; 184(1):59-68. PubMed ID: 15642783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
    Frasor J; Chang EC; Komm B; Lin CY; Vega VB; Liu ET; Miller LD; Smeds J; Bergh J; Katzenellenbogen BS
    Cancer Res; 2006 Jul; 66(14):7334-40. PubMed ID: 16849584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
    Elloso MM; Phiel K; Henderson RA; Harris HA; Adelman SJ
    J Endocrinol; 2005 May; 185(2):243-52. PubMed ID: 15845917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
    Leblanc K; Sexton E; Parent S; Bélanger G; Déry MC; Boucher V; Asselin E
    Int J Oncol; 2007 Feb; 30(2):477-87. PubMed ID: 17203231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.